Reaching new heights in branding

February 15, 2006
Sales and Marketing

The pharma industry has come a long way from the days when it believed that products were all about safety …

Talman and Crozier launch new PR agency

February 14, 2006
Medical Communications

Two senior healthcare PR executives have launched Just:: a new agency which they say will redefine the traditional client/agency relationship.Emma …

Abbott suspended from ABPI over sleaze

February 10, 2006
Sales and Marketing ethics

All expenses paid trips for doctors to see greyhound racing, visits to Wimbledon centre court and even a lap dancing …

More Tamiflu released for UK areas hit by seasonal flu

February 10, 2006
Sales and Marketing

Extra supplies of anti-viral treatment Tamiflu are to be made available in areas of the UK suffering from high levels …

GSK looks ahead to surge of products in 2006

February 10, 2006
Sales and Marketing

GlaxoSmithKline has unveiled strong growth in sales and earnings in 2005, and is preparing for a series of key filings, …

GSK’s research chief leaves for Gates Foundation

February 9, 2006
Research and Development

GlaxoSmithKline's head of research and development Tachi Yamada is to leave the company, having been recruited by Bill Gates to …

Doctors warn on new medical assistant proposals

February 9, 2006

 Doctors have warned that patients may be confused by new non-medically trained assistants, who the government want to carry out …

Pfizer considers sale of OTC division

February 8, 2006
Sales and Marketing

Pfizer says it is considering selling off its consumer medicines division as part of a new drive to improve flagging …

Big drop in animal rights attacks

January 31, 2006
Sales and Marketing

The number of attacks by animal rights extremists saw a significant fall in 2005, with new laws introduced during the …

Europe approves first ever biotech generic

January 30, 2006
Sales and Marketing

Europe's medicines regulator has approved Sandoz's Omnitrope, the world's first generic equivalent or 'biosimilar' of an existing biotech drug.Patents on …

Merck battling more lawsuits over Vioxx

January 27, 2006
Sales and Marketing

Merck says that it will conduct a vigorous defence in the lawsuit brought by the family of Leonel Garza, who …

‘Break even culture’ must end, Hewitt tells NHS

January 27, 2006

Health secretary Patricia Hewitt has unveiled the strategic and financial framework for the NHS in 2006/7, re-stating the government's pledge …

Humira becomes Britain’s first biotech blockbuster

January 26, 2006
Research and Development

The UK biotech company which discovered rheumatoid arthritis drug Humira has hailed its success after sales passed the $1 billion …

Eisai invests

January 26, 2006
Manufacturing and Production

Japanese pharma company Eisai is to open a major new single site facility in the UK, marking the country out …

Amgen to expand R&D investment in UK

January 26, 2006
Research and Development

Amgen, the world's largest biotechnology company is to open a new drug development centre in Uxbridge, London, as part of …

Helping marketers to break ranks

January 26, 2006
Business Services

In the pharma industry personnel development seems to be viewed from a short-term perspective. Where personnel development is undertaken, process …

Limited access to Alzheimer’s drugs leaves patients groups dissatisfied

January 25, 2006
Sales and Marketing

Patient groups have expressed disappointment at NICE plans to allow only some patients with Alzheimer's disease to have drug treatment, …

Roche and biotech swap roles in novel collaboration

January 24, 2006
Research and Development

Roche and Amira Pharmaceuticals have entered into a new and unorthodox drug discovery and development partnership which will see them …

Mergers will create gulf between GPs and PCTs

January 20, 2006

Health service leaders have warned that planned mergers of Primary Care Trusts in England will create larger bodies more remote …

Wyeth submits follow-up to antidepressant blockbuster

January 20, 2006
Sales and Marketing

Wyeth has submitted its new antidepressant desvenlafaxine to the FDA, a drug it hopes will be a successor to its …

The Gateway to Local Adoption Series

Latest content